Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: ROIV stock price vs VZ: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VZ's multiple
Needs VZ P/S.
Implied fair value · at ROIV's multiple
Needs ROIV P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ROIV FY 2026 (ended Mar 31, 2026) · VZ FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
ROIVANT SCIENCES LTD. · implied price per share
Bear
$4.51
Base
$5.30
Bull
$6.10
VERIZON COMMUNICATIONS INC · implied price per share
Bear
$69.51
Base
$81.78
Bull
$94.04
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.10x
1.11x
Net debt / EBITDA
Leverage against operating earnings
32.78x
1.88x
Cash and equivalents
Liquid reserves on the balance sheet
$4.29B
$19.40B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Revolution Medicines, Inc.
ROIV vs RVMD
INCYTE CORP
ROIV vs INCY
Sarepta Therapeutics, Inc.
ROIV vs SRPT
EXELIXIS, INC.
ROIV vs EXEL
VERTEX PHARMACEUTICALS INC / MA
ROIV vs VRTX
AT&T INC.
ROIV vs T
COMCAST CORP
ROIV vs CMCSA
T-Mobile US, Inc.
ROIV vs TMUS
Clearfield, Inc.
ROIV vs CLFD
EchoStar CORP
ROIV vs SATS
CHARTER COMMUNICATIONS, INC. /MO/
ROIV vs CHTR
$442.59M
$117.10B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe ROIV can rapidly reverse its revenue decline and normalize margins from deeply negative levels, then avoid using VZ-style valuation benchmarks alone; otherwise, the current ROIV price looks difficult to justify because VZ comparison shows extreme multiple expansion versus materially stronger fundamentals at VZ.
ROIV’s current price of $34.96 sits near the top of its historical band of $31.46-$38.46, yet VZ-implied value under the provided P/S framework is only $0.02-$4.84. The valuation gap is driven by ROIV’s extremely high P/S of 3044.3x and EV/Revenue of 2578.3x versus VZ at 1.3x and 2.0x, respectively.
Supporting Metrics
